• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服埃索美拉唑和奥美拉唑对胃内pH值的早期影响。

Early effects of oral administration of esomeprazole and omeprazole on the intragastric pH.

作者信息

Iida Hiroshi, Inamori Masahiko, Okuno Kotone, Sekino Yusuke, Sakai Eiji, Okubo Hidenori, Higurashi Takuma, Endo Hiroki, Hosono Kunihiro, Yoneda Masato, Koide Tomoko, Takahashi Hirokazu, Goto Ayumu, Kubota Kensuke, Saito Satoru, Maeda Shin, Nakajima Atsushi, Gotoh Eiji

出版信息

Hepatogastroenterology. 2015 Mar-Apr;62(138):493-6.

PMID:25916088
Abstract

BACKGROUND/AIMS: The aim of our study was to investigate the inhibitory effects on gastric acid secretion of a single oral dose of a proton pump inhibitor, esomeprazole 20 mg and omeprazole 20 mg.

METHODOLOGY

A total of 14 Helicobacter pylori-negative male subjects participated in this study. Intragastric pH was monitored continuously for 6 hours after a single oral dose of omeprazole 20 mg and a single oral dose of esomeprazole 20 mg. Each administration was separated by a 7-day washout period.

RESULTS

During the 6-hour study period, the average pH after administration of esomeprazole was higher than that after the administration of omeprazole. Also during the 6-hour study period, each of pH > 2, 3, 3.5, 4, and 5 was maintained for a longer duration after administration of esomeprazole 20 mg than after administration of omeprazole 20 mg (median: 75.4% vs. 53.8%, p = 0.0138; 52.1% vs. 33.4%, p = 0.0188; 45.8% vs. 28.2%, p = 0.0262; 42.5% vs. 20.7%, p = 0.0414; 35.8% vs. 11.6%, p = 0.0262; respectively).

CONCLUSIONS

In Helicobacter pylori-negative healthy male subjects, single oral administration of esomeprazole 20 mg increased the intragastric pH more rapidly than single oral administration of omeprazole 20 mg.

摘要

背景/目的:我们研究的目的是调查单次口服一剂质子泵抑制剂埃索美拉唑20毫克和奥美拉唑20毫克对胃酸分泌的抑制作用。

方法

共有14名幽门螺杆菌阴性的男性受试者参与了本研究。在单次口服20毫克奥美拉唑和单次口服20毫克埃索美拉唑后,连续6小时监测胃内pH值。每次给药间隔7天的洗脱期。

结果

在6小时的研究期间,服用埃索美拉唑后的平均pH值高于服用奥美拉唑后的平均pH值。同样在6小时的研究期间,服用20毫克埃索美拉唑后,pH>2、3、3.5、4和5的每种情况维持的时间都比服用20毫克奥美拉唑后更长(中位数:75.4%对53.8%,p = 0.0138;52.1%对33.4%,p = 0.0188;45.8%对28.2%,p = 0.0262;42.5%对20.7%,p = 0.0414;35.8%对11.6%,p = 0.0262;分别)。

结论

在幽门螺杆菌阴性的健康男性受试者中,单次口服20毫克埃索美拉唑比单次口服20毫克奥美拉唑能更快地提高胃内pH值。

相似文献

1
Early effects of oral administration of esomeprazole and omeprazole on the intragastric pH.口服埃索美拉唑和奥美拉唑对胃内pH值的早期影响。
Hepatogastroenterology. 2015 Mar-Apr;62(138):493-6.
2
Twice-daily dosing of esomeprazole effectively inhibits acid secretion in CYP2C19 rapid metabolisers compared with twice-daily omeprazole, rabeprazole or lansoprazole.埃索美拉唑一日两次给药较奥美拉唑、雷贝拉唑或兰索拉唑能更有效地抑制 CYP2C19 快速代谢者的胃酸分泌。
Aliment Pharmacol Ther. 2013 Nov;38(9):1129-37. doi: 10.1111/apt.12492. Epub 2013 Sep 16.
3
Potent Gastric Acid Inhibition Over 24 Hours by 4-Times Daily Dosing of Esomeprazole 20 mg.每日服用4次20毫克埃索美拉唑可实现24小时强效胃酸抑制。
Digestion. 2015;91(4):277-85. doi: 10.1159/000381419. Epub 2015 Apr 28.
4
A comparison of the acid-inhibitory effects of esomeprazole and rabeprazole in relation to pharmacokinetics and CYP2C19 polymorphism.埃索美拉唑和雷贝拉唑的抑酸作用比较与药代动力学和 CYP2C19 多态性的关系。
Aliment Pharmacol Ther. 2012 Apr;35(7):810-8. doi: 10.1111/j.1365-2036.2012.05014.x. Epub 2012 Feb 13.
5
Effects of different omeprazole dosing on gastric pH in non-variceal upper gastrointestinal bleeding: A randomized prospective study.不同剂量奥美拉唑对非静脉曲张性上消化道出血患者胃内pH值的影响:一项随机前瞻性研究。
J Dig Dis. 2016 Sep;17(9):588-599. doi: 10.1111/1751-2980.12393.
6
Oral buffered esomeprazole is superior to i.v. pantoprazole for rapid rise of intragastric pH: a wireless pH metry analysis.口服缓冲型埃索美拉唑迅速升高胃内 pH 值优于静脉注射泮托拉唑:一项无线 pH metry 分析。
J Gastroenterol Hepatol. 2010 Jan;25(1):43-7. doi: 10.1111/j.1440-1746.2009.05994.x. Epub 2009 Oct 27.
7
Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP2C19 genotype.与埃索美拉唑相比,沃克唑仑对胃酸的强效抑制作用,参考CYP2C19基因型
Aliment Pharmacol Ther. 2016 May;43(10):1048-59. doi: 10.1111/apt.13588. Epub 2016 Mar 18.
8
Effect of esomeprazole and rabeprazole on intragastric pH in healthy Chinese: an open, randomized crossover trial.埃索美拉唑和雷贝拉唑对健康中国人群胃内pH值的影响:一项开放、随机交叉试验。
J Gastroenterol Hepatol. 2007 Jun;22(6):815-20. doi: 10.1111/j.1440-1746.2006.04709.x.
9
Intragastric acidity during administration of generic omeprazole or esomeprazole - a randomised, two-way crossover study including CYP2C19 genotyping.给予通用奥美拉唑或埃索美拉唑时的胃内酸度 - 一项包括 CYP2C19 基因分型的随机、两向交叉研究。
Aliment Pharmacol Ther. 2011 Feb;33(4):471-6. doi: 10.1111/j.1365-2036.2010.04544.x. Epub 2010 Dec 22.
10
The pharmacokinetics, pharmacodynamics and safety of oral doses of ilaprazole 10, 20 and 40 mg and esomeprazole 40 mg in healthy subjects: a randomised, open-label crossover study.健康受试者口服10毫克、20毫克和40毫克伊拉普唑以及40毫克埃索美拉唑的药代动力学、药效学和安全性:一项随机、开放标签交叉研究。
Aliment Pharmacol Ther. 2014 Sep;40(5):548-61. doi: 10.1111/apt.12860. Epub 2014 Jul 13.

引用本文的文献

1
Pharmacokinetics and pharmacodynamics of intravenous esomeprazole at 2 different dosages in dogs.静脉注射不同剂量埃索美拉唑在犬体内的药代动力学和药效学研究
J Vet Intern Med. 2019 Mar;33(2):531-535. doi: 10.1111/jvim.15383. Epub 2018 Dec 13.
2
Pharmacokinetics and Acid Suppressant Efficacy of Esomeprazole after Intravenous, Oral, and Subcutaneous Administration to Healthy Beagle Dogs.埃索美拉唑在健康比格犬静脉注射、口服和皮下注射后的药代动力学及抑酸效果
J Vet Intern Med. 2017 May;31(3):743-750. doi: 10.1111/jvim.14713. Epub 2017 Apr 13.